Laurie Stelzer Net Worth & Insider Trades

Laurie Stelzer - SVP, Halozyme Therapeutics, Inc

As of February 24, 2020

What is Laurie Stelzer's Net Worth?

The current estimated net worth of Halozyme Therapeutics, Inc's SVP, Laurie Stelzer, is estimated to be about $7.18M . Laurie Stelzer owns about 10,000 units of Halozyme Therapeutics, Inc common stock. In the last 5 years at Halozyme Therapeutics, Inc, Laurie Stelzer has sold an estimated value of $1.13M worth.

What is Laurie Stelzer's Past Insider Trading?

Laurie Stelzer's largest purchase order was 10,000 units , worth over $172.38K on August 24, 2015. In total, Laurie Stelzer has made about 21 transactions over 5 years of their time at Halozyme Therapeutics, Inc. Laurie Stelzer usually trades in February, with the busiest year in 2019 and 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Laurie Stelzer

Date Range: All Time
Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was Laurie Stelzer's Salary in 2020?

As SVP of Halozyme Therapeutics, Inc, Laurie Stelzer has a total base salary of $93,225 . Laurie Stelzer received compensation valued at about $171,221 in 2020 after becoming SVP. The vast majority of their compensation came in the form of other compensation of $77,996 .

What is Laurie Stelzer's' Mailing Address?

  • Mailing address is 6154 Nancy Ridge Drive San Diego CA 92121 CA

Halozyme Therapeutics, Inc Executive Compensation

Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - - - - $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found


What are Halozyme Therapeutics, Inc's Past Insider Trades?

Halozyme Therapeutics, Inc's most recent insider trade came on September 19, 2023 by Michael Labarre who sold 10,000 units worth $390.98K . In the last 16 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $154.9M and bought an estimated value of $85.8M worth of shares. Insider trading is most common in February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO,  Michael Labarre, SVP,  and Gregory Ian Frost, CEO .


Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found